在帕金森病中,结合体下和背侧尼格拉深脑刺激的动力学效应
Daniel Kroneberg1,2, Bassam Al-Fatly1, Cornelia Morkos1
1Department of Neurology with Experimental Neurology, Movement Disorders and Neuromodulation Unit, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Journal of Parkinson's disease
|February 16, 2024
概括
亚thalamic核 (STN) 的深度大脑刺激 (DBS) 改善了帕金森病 (PD) 的步态. 结合STN和黑色物质 (SNr) DBS没有显示出一致的额外益处,这表明需要改进.
科学领域:
- 神经学 神经学
- 神经外科 神经外科
- 生物医学工程 生物医学工程
背景情况:
- 黑色实体 (SNr) 刺激正在探索帕金森病 (PD) 轴症状和步态.
- 步行障碍显著影响PD患者的生活质量.
研究的目的:
- 为了评估结合的脑下核 (STN) 和SNR深脑刺激 (DBS) 对PD步态的影响.
- 在SNR内绘制刺激部位的地图,以实现最佳的向.
主要方法:
- 与10名PD患者进行的双盲交叉研究.
- 临床和动力步行评估,比较STN DBS,联合STN+SNr DBS和OFF DBS.
- 模拟刺激体积以确认SNR重叠.
主要成果:
- 与OFF相比,STN DBS改进了UPDRS III,结,步伐长度,速度和运动范围.
- 结合STN+SNr DBS没有显著的队列水平的改善.
- 个别患者在联合刺激下显示了增加的步态改善.
结论:
- 结合STN和背侧SNR DBS并不总是比单独STN DBS提供额外的短期益处.
- 需要进一步的研究来完善刺激参数和患者选择在PD中SNR DBS.
- 优化SNR内的刺激频率,间隔和目标区域对于未来的试验至关重要.
相关概念视频
01:24Parkinson's Disease: Treatment
268
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
268
01:15Parkinson's Disease: Overview
546
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
546